Condition: Major Cardiovascular Event · Established Atherosclerotic Cardiovascular Disease · Sponsor: Amgen
The primary objective of the study is to evaluate real-world effectiveness of treatment with Repatha® in combination with SOC, compared with SOC alone, on the risk for cardiovascular (CV) death, myocardial infarction (MI), stroke, hospitalization for unstable angina, or coronary revascularization, whichever occurs first, in participants with established atherosclerotic CV disease (ASCVD) treated with SOC, according to local clinical practice.
This description comes directly from the study's public registry record.
Amgen Call Center · 866-572-6436 · medinfo@amgen.com
Always discuss trial participation with your own doctor first.
| Beijing Anzhen Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| China Japan Friendship Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Peking University First Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Fuwai Hospital Chinese Academy of Medical Sciences | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Friendship Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Haidian Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Peking University Third Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Chongqing Emergency Medical Center | Chongqing, Chongqing Municipality, China | Recruiting |
| Chongqing General Hospital | Chongqing, Chongqing Municipality, China | Recruiting |
| Dongguan Songshan Lake Central Hospital | Dongguan, Guangdong, China | Recruiting |
| The First Peoples Hospital of Foshan | Foshan, Guangdong, China | Recruiting |
+ 78 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06295679